期刊
JCI INSIGHT
卷 5, 期 18, 页码 -出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.141115
关键词
-
资金
- US NIH/National Cancer Institute [CA217648, CA123088, CA099985, CA193136, CA152470]
- NIH through the University of Michigan Rogel Cancer Center Grant [CA46592]
Tumor-associated macrophages (TAMs) affect cancer progression and therapy. Ovarian carcinoma often metastasizes to the peritoneal cavity. Here, we found 2 peritoneal macrophage subsets in mice bearing ID8 ovarian cancer based on T cell immunoglobulin and mucin domain containing 4 (Tim-4) expression. Tim-(4+) TAMs were embryonically originated and locally sustained while Tim-4(-) TAMs were replenished from circulating monocytes. Tim-4(+) TAMs, but not Tim-4(-) TAMs, promoted tumor growth in vivo. Relative to Tim-4(-) TAMs, Tim-4(+) TAMs manifested high oxidative phosphorylation and adapted mitophagy to alleviate oxidative stress. High levels of arginase-1 in Tim-4(+) TAMs contributed to potent mitophagy activities via weakened mTORC1 activation due to low arginine resultant from arginase-1-mediated metabolism. Furthermore, genetic deficiency of autophagy element FAK family-interacting protein of 200 kDa resulted in Tim-4(+) TAM loss via ROS-mediated apoptosis and elevated T cell immunity and ID8 tumor inhibition in vivo. Moreover, human ovarian cancer-associated macrophages positive for complement receptor of the immunoglobulin superfamily (CRIg) were transcriptionally, metabolically, and functionally similar to murine Tim-4(+) TAMs. Thus, targeting CRIg(+) (Tim-4(+)) TAMs may potentially treat patients with ovarian cancer with peritoneal metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据